Founders cashed out 490 million yuan, former sponsor CICC mysteriously withdrew! Is Tianxing Medical's Hong Kong IPO a 'cash flow miracle' or a 'capital puzzle'? "Giving up the STAR Market for Hong Kong: Behind the 5.4 billion yuan valuation of the 'domestic sports medicine leader', why is it criticized for poor cost-effectiveness?
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments